Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Regemat 3D
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Idea== <vimeo>671714060</vimeo> Born in 2015 to advance medical technology, developing living tissues such as cartilage, skin and bone to be implanted in patients. Aiming to solve issues caused by ageing, injuries or genetic issues. Over 7 years we have developed two types of 3D bioprinters and two lines of bioreactors. A bioreactor allows the printed tissue to be physically tested before implantation. Additionally, we created an international platform of 3d impression protocols (Labmethods.org) where researchers from all over the world can share their printing protocols and acquire the biomaterials necessary to put such research into practice, a recurring income line for the company. To date, we’ve sold 3d bioprinters to more than a hundred research institutions around the world, which, through the use of biomaterials, can now print, cartilage, meniscus, muscle tissue and spinal cord. Among our clients are University Hospital of Basel (Switzerland), Florida Institute of Technology (USA), University of Western Australia and l'Université libre de Bruxelles, ULB. Independent reports (Markets&Markets 9/2019) indicate that the global 3D bioprinting market will reach 1.6 billion dollars in 2024 with a compound growth rate of 20.4%. The purpose of this crowdfunding round is to finance the expansion of the company, by increasing its sales and marketing capabilities and continue to develop our technology.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)